Full Text Available
Access Full Text at Repository
Search Results - "Diseases"
-
Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
Published in Lung Cancer: Targets and Therapy (2026)Subjects: “…Respiratory Diseases…”
Get full text
Online Article RSS Article -
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report
Published in Lung Cancer: Targets and Therapy (2026)Subjects: “…Respiratory Diseases…”
Get full text
-
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
Published in Lung Cancer: Targets and Therapy (2026)Subjects: “…Respiratory Diseases…”
Get full text
-
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
Published in Lung Cancer: Targets and Therapy (2026)Subjects: “…Respiratory Diseases…”
Get full text
-
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lu...
Published in Lung Cancer: Targets and Therapy (2026)Subjects: “…Respiratory Diseases…”
Get full text
-
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer
Published in Lung Cancer: Targets and Therapy (2026)Subjects: “…Respiratory Diseases…”
Get full text
-
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Pulmonary Nodular Lymphoid Hyperplasia: Reviewing a Lung Cancer Mimicker
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
A Concise Review of the Approved MET TKIs (Savolitinib, Gumarontinib, Vebreltinib, Tepotinib, Capmatinib) in China for MET Exon 14 Splice Site Mutated (METex14+) NSCLC Circa 2025
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case R...
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Tumor Heterogeneity and Plasticity in Small Cell Lung Cancer
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Emerging Targets in Non-Small Cell Lung Cancer
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Sensitive Response to Afatinib: A Case Report and Literature Review
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stag...
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text
-
Prevalence of EGFR Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study
Published in Lung Cancer: Targets and Therapy (2025)Subjects: “…Respiratory Diseases…”
Get full text